Metraipolis › archive › dc_11fa5ff78066

Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Efficacy, Real-World Outcomes, and the Search for Predictive Biomarkers — Europe PMC PMID:41744857

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41744857
DOI
10.3390/curroncol33020093
License (as archived)
solo-consultazione
Archived
2026-11-06T04:08:47.509Z
SHA-256 of the archived text
1b123e7bfa3c5470b07a57676ce1dcf5dda06d224eb43003d2e2271239a8a2c4
Stable URL of this page
https://metraipolis.com/documento/dc_11fa5ff78066

How to cite

Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Efficacy, Real-World Outcomes, and the Search for Predictive Biomarkers — Europe PMC PMID:41744857 — Europe PMC (en), https://europepmc.org/article/MED/41744857 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_11fa5ff78066 (Metraipolis archive dc_11fa5ff78066, sha256 1b123e7bfa3c5470b07a57676ce1dcf5dda06d224eb43003d2e2271239a8a2c4)
BibTeX
@misc{dc11fa5ff78066,
  title = {Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Efficacy, Real-World Outcomes, and the Search for Predictive Biomarkers — Europe PMC PMID:41744857},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41744857},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_11fa5ff78066; sha256 1b123e7bfa3c5470b07a57676ce1dcf5dda06d224eb43003d2e2271239a8a2c4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41744857. Agents can read the archived copy with the MCP tool read_document.